Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for secondary iron overload in hereditary anemia
2017-003777-34Phase 3Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of esomeprazole in Secondary Hemosiderosis and iron overload (2 arms), sponsored by University Medical Center Utrecht. Primary endpoint: Change in liver iron concentration. Started Feb 2018; status: completed.
02
Drugs
esomeprazole
03
Conditions
Secondary Hemosiderosisiron overload
Beyond the preview
Go deeper on 2017-003777-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-003777-34.